ロード中...
Endocan as a prognostic biomarker of triple-negative breast cancer
PURPOSE: Triple-negative breast cancer (TNBC) has aggressive characteristics and fewer treatment options than other subtypes. The purpose of this study was to explore prognostic biomarkers for TNBC that can be easily detected from the blood samples. METHODS: MDA-MB-231 and MDA-MB-231BR, a brain meta...
保存先:
| 出版年: | Breast Cancer Res Treat |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer US
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5225208/ https://ncbi.nlm.nih.gov/pubmed/27888420 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-016-4057-8 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|